Divi’s Laboratories Limited has announced strong financial results for the fiscal year ended March 31, 2026. The company achieved a consolidated total income of ₹11,067 crore and a profit after tax of ₹2,568 crore. In light of this performance, the Board of Directors has recommended a final dividend of ₹30 per share, representing a 1,500% payout. The 36th Annual General Meeting is scheduled for August 10, 2026.
Financial Highlights
For the financial year ended March 31, 2026, Divi’s Laboratories reported a consolidated total income of ₹11,067 crore, up from ₹9,712 crore in the previous year. The company’s profit after tax (PAT) reached ₹2,568 crore, compared to ₹2,191 crore for the previous financial year. These results reflect a strong operational performance despite the impact of new labour codes, which incurred a non-recurring cost of ₹74 crore.
Quarterly Performance Analysis
In the fourth quarter (Jan-Mar 2026), the company recorded a consolidated total income of ₹2,986 crore, an increase over the ₹2,671 crore reported in the same quarter of the previous year. Profit after tax for this quarter stood at ₹751 crore, up from ₹662 crore in the corresponding quarter of the previous year. A notable contributor to these results was a forex gain of ₹90 crore during this quarter.
Dividend and Shareholders’ Meeting
The Board of Directors has recommended a final dividend of ₹30 per equity share on a face value of ₹2 each for the financial year 2025-26. This dividend proposal is subject to approval by shareholders at the company’s 36th Annual General Meeting, which is set to take place on August 10, 2026. The record date for determining eligibility for the dividend payment has been fixed as July 24, 2026.
Source: BSE
